Gore will take ownership of InnAVasc’s arteriovenous graft, the report said. InnAVasc CEO Joseph Knight, PhD, told WRAL that the company sees “an array of synergies working with Gore.”
Financial terms were not disclosed.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
